Position in AZN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,257,559
+$495,304 QoQ
Shares Held
6,632
+71.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#620
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealthspire Advisors, LLC holds $100,760,753 across 13 Drug Manufacturers - General names. AZN ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,830 | $33,380,139 | |
| 2 | JNJ |
Johnson & Johnson
|
101,693 | $25,826,971 | |
| 3 | ABBV |
AbbVie Inc.
|
67,367 | $16,952,231 | |
| 4 | MRK |
Merck & Co., Inc.
|
75,165 | $9,658,702 | |
| 5 | AMGN |
Amgen Inc
|
13,416 | $4,858,201 | |
| 6 | PFE |
Pfizer Inc
|
141,769 | $3,413,797 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
40,673 | $2,343,578 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
6,632 | $1,257,559 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,257,559 | 6,632 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $762,255 | 3,865 | Shares | Sole | 2026-05-01 | |
| No filing history on record for this holder in this stock. | ||||||